Fisher Biosciences, Applied Biosystems form licensing agreement for PCR rights

By Lisa Kerner

Charlotte, N.C., June 29 - Fisher Biosciences said it has entered into an expanded PCR (polymerase chain reaction) licensing agreement through Fisher Scientific with Applied Biosystems, an Applera Corp., to develop real-time PCR and PCR-related reagents.

Under the agreement, Fisher has access to patents not covered in Applied Biosystems' original licensing program, according to a company news release.

Also, ABgene, a unit of Fisher Biosciences, can develop real-time PCR reagent products and technologies through collaboration with other Fisher Biosciences units.

PCR technology is used in life science research to copy or amplify a segment of DNA or RNA for analysis.

Located in Epson, U.K., Fisher Biosciences manufactures and supplies products and services to the general-chemistry and life-sciences markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.